A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
Category: Drugs (Pharmaceuticals)
-
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
-
FDA Approves New Drug to Treat Hot Flashes
It is the first nonhormonal treatment for the menopause symptom.
-
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds
Black patients with opioid use disorder were far less likely to fill prescriptions for the most effective addiction treatments than white patients. But strikingly few patients of all races got the medicine.
-
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
-
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
-
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.
-
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
-
National Academies Members Demand Answers About Sacklers’ Donations
The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
-
F.D.A. Approves Drug for Rare Form of A.L.S.
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.
-
The Fight Over a Drug That Is Great for Horses but Horrific for Humans
Drug dealers are mixing xylazine, an animal tranquilizer relied on by veterinarians, into fentanyl, with deadly results. But controlling it is tricky.